send to a friend by email

Jerusalem Pharmaceuticals earns a pretax income of JD 776.5 thousand in the first quarter of 2010

2010-05-02

Jerusalem Pharmaceuticals (JPH) disclosed its financial statements for the first quarter of 2010, and the company’s financial results as of 31/03/2010 indicated a pretax income of JD 776,525 comparing to a pretax income of JD 319,481 in the first quarter of 2009. The company’s assets reached JD 25,547,608 at the end 31/03/2010 after they reached JD 24,947,457 on 31/12/2009. Total liabilities reached JD 3,356,458 at the end of the first quarter of 2010 comparing to JD 3,600,190 as of 31/12/2009. Shareholders’ equity reached JD 22,191,150 (minority interests of JD 109,226) on 31/03/2010 after they reached JD 21,347,267 (minority interests of JD 108,347) at the end of 2009.